tiprankstipranks
Trending News
More News >
Chemical Industries Far East Ltd. (SG:C05)
SGX:C05
Singapore Market
Advertisement

Chemical Industries Far East Ltd. (C05) AI Stock Analysis

Compare
0 Followers

Top Page

SG:C05

Chemical Industries Far East Ltd.

(SGX:C05)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
S$0.48
▼(-1.04% Downside)
The overall stock score is primarily impacted by the company's declining financial performance and bearish technical indicators. The negative P/E ratio further contributes to a poor valuation score. Despite a strong balance sheet, operational inefficiencies and cash flow challenges are significant concerns.
Positive Factors
Strong Balance Sheet
A strong balance sheet with low leverage provides financial stability and flexibility, allowing the company to navigate operational challenges and invest in growth opportunities.
Strategic Partnerships
Strategic partnerships enhance innovation and product development, enabling the company to meet emerging market demands and maintain competitive advantages.
Focus on Sustainability
Emphasizing sustainability aligns with global trends and regulatory requirements, potentially expanding the customer base and ensuring long-term growth.
Negative Factors
Declining Revenue
Declining revenue indicates potential loss of market share or demand, which can impact long-term growth prospects and financial performance.
Negative Profit Margins
Negative profit margins suggest inefficiencies and cost management issues, which may hinder the company's ability to generate sustainable profits.
Cash Flow Challenges
Negative free cash flow can limit the company's ability to invest in growth and meet financial obligations, affecting long-term financial health.

Chemical Industries Far East Ltd. (C05) vs. iShares MSCI Singapore ETF (EWS)

Chemical Industries Far East Ltd. Business Overview & Revenue Model

Company DescriptionChemical Industries (Far East) Limited, an investment holding company, manufactures and sells chemicals in Singapore and Myanmar. The company operates in two segments, Industrial Chemicals and Properties. It offers sodium hypochlorite, chlorine, hydrochloric acid, and calcium hydroxide for water treatment chemicals and electronics; and distribution and transportation services. The company also manages and rents commercial properties. In addition, it operates as a general merchant, importer, and exporter of chemicals. The company was incorporated in 1962 and is based in Singapore.
How the Company Makes MoneyThe company generates revenue primarily through the sale of its specialty chemicals and industrial products to various sectors. Key revenue streams include direct sales to end-users, distribution partnerships with local and regional suppliers, and long-term contracts with major industrial clients. Additionally, Chemical Industries Far East Ltd. benefits from strategic partnerships with research institutions and technology providers, allowing them to innovate and introduce new products that meet emerging market demands. The company's focus on sustainability and regulatory compliance also attracts clients looking for eco-friendly solutions, further contributing to its revenue growth.

Chemical Industries Far East Ltd. Financial Statement Overview

Summary
Chemical Industries Far East Ltd. faces significant operational challenges, as evidenced by declining revenue and profitability. Despite a strong balance sheet with low leverage, the negative return on equity and cash flow issues highlight areas of concern. The company needs to address its operational inefficiencies to improve its financial health.
Income Statement
45
Neutral
The income statement shows a concerning trend with declining revenue and profitability. The company experienced a negative revenue growth rate of -1.3% in the latest period, and both EBIT and net profit margins are negative, indicating operational challenges. Historically, the company had positive margins, but recent performance has deteriorated significantly.
Balance Sheet
65
Positive
The balance sheet remains relatively stable with a low debt-to-equity ratio of 0.015, suggesting conservative leverage. However, the return on equity has turned negative, reflecting the company's recent losses. The equity ratio is healthy, indicating a strong equity base relative to assets.
Cash Flow
50
Neutral
Cash flow analysis reveals mixed results. While operating cash flow is positive, free cash flow remains negative, although it has improved significantly. The operating cash flow to net income ratio is below 1, indicating potential cash flow challenges relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue65.37M65.37M72.58M100.03M85.00M63.00M
Gross Profit3.84M3.84M5.63M6.93M22.07M19.31M
EBITDA-18.32M-15.09M11.73M8.91M11.06M14.08M
Net Income-21.46M-21.46M4.87M3.55M6.80M5.57M
Balance Sheet
Total Assets138.13M138.13M147.52M146.41M152.65M145.41M
Cash, Cash Equivalents and Short-Term Investments23.47M23.47M21.44M29.44M44.98M41.74M
Total Debt6.71M6.71M2.60M3.59M4.69M5.53M
Total Liabilities31.95M31.95M18.31M21.04M22.26M20.68M
Stockholders Equity106.18M106.18M129.21M125.37M130.39M124.74M
Cash Flow
Free Cash Flow518.00K-621.00K-7.05M-14.39M4.21M12.00M
Operating Cash Flow10.27M9.13M4.81M-8.63M6.07M14.77M
Investing Cash Flow-14.61M-9.74M-11.84M-5.73M-1.87M-2.61M
Financing Cash Flow2.90M3.07M-1.08M-1.05M-990.00K-2.16M

Chemical Industries Far East Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.48
Price Trends
50DMA
0.55
Negative
100DMA
0.54
Negative
200DMA
0.51
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
29.87
Positive
STOCH
-5.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C05, the sentiment is Negative. The current price of 0.48 is below the 20-day moving average (MA) of 0.53, below the 50-day MA of 0.55, and below the 200-day MA of 0.51, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 29.87 is Positive, neither overbought nor oversold. The STOCH value of -5.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C05.

Chemical Industries Far East Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
46
Neutral
S$39.87M-1.86-19.55%1.03%-7.45%-480.22%
45
Neutral
S$55.68M-2.37-20.85%-2.43%52.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C05
Chemical Industries Far East Ltd.
0.49
0.02
4.30%
SG:5DS
MegaChem Ltd.
0.40
-0.02
-4.76%
SG:A55
Asia Enterprises Holding Ltd.
0.17
0.05
41.67%
SG:BTX
Anchun International Holdings Ltd.
0.42
0.15
55.56%
SG:C8R
Jiutian Chemical Group Limited
0.03
0.00
0.00%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.10
0.04
66.67%

Chemical Industries Far East Ltd. Corporate Events

Chemical Industries Announces Committee Restructuring
Oct 1, 2025

Chemical Industries (Far East) Limited has announced a reconstitution of its Remuneration and Audit and Risk Committees, effective from October 1, 2025. The changes involve Mr. Lim Chee San and Mr. Yeo Hock Chye swapping their roles as chairmen of the respective committees, which may impact the company’s governance and oversight structures.

Chemical Industries Far East Ltd. Convenes Annual General Meeting
Aug 15, 2025

Chemical Industries Far East Ltd. held its Annual General Meeting on July 28, 2025, in Singapore, where key company figures, including the Chairman, CEO, and other directors, were present. The meeting proceeded with the confirmation of a quorum and the reading of the AGM notice, indicating the company’s adherence to formal governance processes.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 02, 2025